GD-11
/ Wangao Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 12, 2024
GD-11 for Injection in the Treatment of Acute Ischemic Stroke
(clinicaltrials.gov)
- P3 | N=980 | Recruiting | Sponsor: Beijing Tiantan Hospital
New P3 trial • Cardiovascular • Ischemic stroke
1 to 1
Of
1
Go to page
1